Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss.

Lindtner, R A

Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss. [electronic resource] - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Mar 2014 - 1151-61 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1433-2965

10.1007/s00198-013-2494-3 doi


Aged
Aged, 80 and over
Alendronate--pharmacology
Alkaline Phosphatase--metabolism
Bone Density--drug effects
Bone Density Conservation Agents--pharmacology
Cell Differentiation--drug effects
Cells, Cultured
Diphosphonates--pharmacology
Female
Humans
Imidazoles--pharmacology
Mesenchymal Stem Cells--drug effects
Osteogenesis--drug effects
Osteopontin--physiology
Osteoporosis, Postmenopausal--drug therapy
Zoledronic Acid